Researchers are designing nanoparticles to treat inflammatory bowel diseases such as such as Chron’s disease and ulcerative colitis. Key innovations are the design of self-assembling nanoparticles that carry drugs and naturally target inflamed colons. The nanoparticles could deliver relief to more than 3 million Americans who suffer from the diseases.